1.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: LAL-RI/96, NCT00494897
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: LAL-Ph-2000, NCT00526305
|
|
4.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
|
|
5.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 20
Sponsor: NCI
Protocol IDs: POG-8698
|
|
6.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: POG-8741/42, POG-8741, POG-8742
|
|
7.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 75
Sponsor: NCI
Protocol IDs: EST-1878
|
|
8.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1588
|
|
9.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: EORTC-08891
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 50 and over
Sponsor:
Protocol IDs: EORTC-20932
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 21 at diagnosis
Sponsor: NCI
Protocol IDs: POG-9406, POG-ALINC-16/HR
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D81-043-156, MDA-DT-8071
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor:
Protocol IDs: BTSG-8001
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 16
Sponsor: NCI
Protocol IDs: CCG-371
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8104/05
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 16
Sponsor: NCI
Protocol IDs: CCG-371P/373P
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: CCG-121
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-797251, NCCTG-79-72-51
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor:
Protocol IDs: NCI-D81-050-885, SJCRH-NB-79-B
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor:
Protocol IDs: NCI-D82-006-762, YALE-HIC-2571
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 18
Sponsor:
Protocol IDs: UCCRC-3583, ICC-82L3, NCI-D82-014-968
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor:
Protocol IDs: SJCRH-TOT-10S, NCI-D81-050-884
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8304, POG-SIMAL-4
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: COG-8303, POG-8303
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: SJCRH-NB-84, NCI-T84-0167D, T84-0167
|
Mobile | Español
